HIV-1 Vpu affects the anterograde transport and the glycosylation pattern of NTB-A.

HIV-1 Vpu induces downregulation of cell surface NTB-A to evade lysis of HIV-1 infected cells by NK cells. Here we show that Vpu affects the anterograde transport and the glycosylation pattern of NTB-A by a mechanism that is distinct from the Vpu induced downregulation of CD4 and tetherin. In the presence of Vpu, only the high mannose form of NTB-A was detectable, suggesting that Vpu prevented the formation of the mature form of NTB-A. This phenomenon is associated with the ability of Vpu to downregulate cell surface NTB-A by retention of NTB-A within the Golgi-compartment. Furthermore, the Vpu-mediated effect on NTB-A glycosylation is highly conserved among Vpu proteins derived from HIV-1 and SIV and corresponds to the level of downregulation of NTB-A. Together, these results suggest that the reduction of NTB-A from the cell surface is associated with the Vpu-mediated effect on the glycosylation pattern of newly synthesized NTB-A molecules.

[1]  P. Bastiaens,et al.  The Palmitoylation Machinery Is a Spatially Organizing System for Peripheral Membrane Proteins , 2010, Cell.

[2]  Marc C. Johnson,et al.  The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. , 2008, Cell host & microbe.

[3]  T. J. Stillman,et al.  The three-dimensional structure of PNGase F, a glycosylasparaginase from Flavobacterium meningosepticum. , 1994, Structure.

[4]  M Montal,et al.  Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Bieniasz,et al.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu , 2008, Nature.

[6]  P. Scheiffele,et al.  VIP36 localisation to the early secretory pathway. , 1999, Journal of cell science.

[7]  S. Neil,et al.  Separable Determinants of Subcellular Localization and Interaction Account for the Inability of Group O HIV-1 Vpu To Counteract Tetherin , 2011, Journal of Virology.

[8]  F. Maldarelli,et al.  Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein , 1993, Journal of virology.

[9]  A. Veillette,et al.  Control of T Lymphocyte Signaling by Ly108, a Signaling Lymphocytic Activation Molecule Family Receptor Implicated in Autoimmunity* , 2008, Journal of Biological Chemistry.

[10]  É. Cohen,et al.  Suppression of Tetherin-Restricting Activity upon Human Immunodeficiency Virus Type 1 Particle Release Correlates with Localization of Vpu in the trans-Golgi Network , 2009, Journal of Virology.

[11]  T. Klimkait,et al.  The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release , 1990, Journal of virology.

[12]  George Banting,et al.  Bst‐2/HM1.24 Is a Raft‐Associated Apical Membrane Protein with an Unusual Topology , 2003, Traffic.

[13]  P. Gage,et al.  The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels , 1996, Journal of virology.

[14]  J. Fritz,et al.  HIV-1 Vpu Blocks Recycling and Biosynthetic Transport of the Intrinsic Immunity Factor CD317/Tetherin To Overcome the Virion Release Restriction , 2011, mBio.

[15]  E. Wingender,et al.  The Human Immunodeficiency Virus Type 1 Encoded Vpu Protein is Phosphorylated by Casein Kinase-2 (CK-2) at Positions Ser52 and Ser56 within a Predicted α-Helix-Turn-α-Helix-Motif , 1994 .

[16]  Cheng-Chang Chen,et al.  BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: evidence for a post-ER mechanism of Vpu-action. , 2011, Virology.

[17]  P. Henklein,et al.  Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV‐1‐infected cells , 1996, FEBS letters.

[18]  M. Schindler,et al.  Macrophage Internal HIV-1 Is Protected from Neutralizing Antibodies , 2011, Journal of Virology.

[19]  T. Sata,et al.  HIV-1 Accessory Protein Vpu Internalizes Cell-surface BST-2/Tetherin through Transmembrane Interactions Leading to Lysosomes* , 2009, The Journal of Biological Chemistry.

[20]  J. Sodroski,et al.  Identification of a protein encoded by the vpu gene of HIV-1 , 1988, Nature.

[21]  H. Gendelman,et al.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.

[22]  E. Zimmerman,et al.  HIV-1 Vpr Triggers Natural Killer Cell–Mediated Lysis of Infected Cells through Activation of the ATR-Mediated DNA Damage Response , 2009, PLoS pathogens.

[23]  Marc C. Johnson,et al.  Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells , 2009, Cell.

[24]  C. Watzl,et al.  Cutting Edge: NTB-A Activates NK Cells via Homophilic Interaction1 , 2004, The Journal of Immunology.

[25]  J. Luban,et al.  HIV-1 Vpu Neutralizes the Antiviral Factor Tetherin/BST-2 by Binding It and Directing Its Beta-TrCP2-Dependent Degradation , 2009, PLoS pathogens.

[26]  M. Martin,et al.  Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4 , 1992, Journal of virology.

[27]  Daniel Rupp,et al.  Antagonism of CD317 Restriction of Human Immunodeficiency Virus Type 1 (HIV-1) Particle Release and Depletion of CD317 Are Separable Activities of HIV-1 Vpu , 2010, Journal of Virology.

[28]  Min Li,et al.  Membrane receptor trafficking: Evidence of proximal and distal zones conferred by two independent endoplasmic reticulum localization signals , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Greenough,et al.  Down-Modulation of Mature Major Histocompatibility Complex Class II and Up-Regulation of Invariant Chain Cell Surface Expression Are Well-Conserved Functions of Human and Simian Immunodeficiency Virus nef Alleles , 2003, Journal of Virology.

[30]  M. Latterich,et al.  Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum , 2007, Retrovirology.

[31]  A. Santoni,et al.  The Human Immunodeficiency Virus Type 1 Nef and Vpu Proteins Downregulate the Natural Killer Cell-Activating Ligand PVR , 2012, Journal of Virology.

[32]  É. Cohen,et al.  Antagonism of Tetherin Restriction of HIV-1 Release by Vpu Involves Binding and Sequestration of the Restriction Factor in a Perinuclear Compartment , 2010, PLoS pathogens.

[33]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[34]  E. Wingender,et al.  The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. , 1994, Journal of molecular biology.

[35]  W. Hardy.  The human immunodeficiency virus. , 1996, The Medical clinics of North America.

[36]  J. Yewdell,et al.  CD4 Glycoprotein Degradation Induced by Human Immunodeficiency Virus Type 1 Vpu Protein Requires the Function of Proteasomes and the Ubiquitin-Conjugating Pathway , 1998, Journal of Virology.

[37]  Y. Misumi,et al.  Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. , 1986, The Journal of biological chemistry.

[38]  T. Bektimirov.  [The human immunodeficiency virus type 2]. , 1990, Voprosy virusologii.

[39]  M. van Lookeren Campagne,et al.  NTB-A, a New Activating Receptor in T Cells That Regulates Autoimmune Disease* , 2004, Journal of Biological Chemistry.

[40]  A. Moses,et al.  Vpu Directs the Degradation of the Human Immunodeficiency Virus Restriction Factor BST-2/Tetherin via a βTrCP-Dependent Mechanism , 2009, Journal of Virology.

[41]  A. Zilberstein,et al.  The interferon-induced protein kinase PK-i from mouse L cells. , 1979, Journal of Biological Chemistry.

[42]  J. Tkacz,et al.  Tunicamycin inhibition of polyisoprenyl N-acetylglucosaminyl pyrophosphate formation in calf-liver microsomes. , 1975, Biochemical and biophysical research communications.

[43]  E. Campbell,et al.  Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. , 2010, Cell host & microbe.

[44]  J. Hauber,et al.  A Flow Cytometry-Based FRET Assay to Identify and Analyse Protein-Protein Interactions in Living Cells , 2010, PloS one.

[45]  M. Wainberg,et al.  The Transmembrane Domain of BST-2 Determines Its Sensitivity to Down-Modulation by Human Immunodeficiency Virus Type 1 Vpu , 2009, Journal of Virology.

[46]  G. Learn,et al.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. , 2009, Cell host & microbe.

[47]  M. A. Abdul Jabbar,et al.  The human immunodeficiency virus type 1 Vpu protein: a potential regulator of proteolysis and protein transport in the mammalian secretory pathway. , 1995, Virology.

[48]  M. Wainberg,et al.  The HIV-1 Vpu Viroporin Inhibitor BIT225 Does Not Affect Vpu-Mediated Tetherin Antagonism , 2011, PloS one.

[49]  Javier G. Magadán,et al.  Multilayered Mechanism of CD4 Downregulation by HIV-1 Vpu Involving Distinct ER Retention and ERAD Targeting Steps , 2010, PLoS pathogens.

[50]  F. Kirchhoff,et al.  Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue , 2010, Retrovirology.

[51]  D. Thomas,et al.  A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. , 1998, Molecular cell.

[52]  U. Schubert,et al.  Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317. , 2011, Virology.

[53]  A. Telenti,et al.  Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation. , 2007, Journal of virology.

[54]  F. Maldarelli,et al.  Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity , 1993, Journal of virology.

[55]  T. J. Stillman,et al.  The three-dimensional structure of PNGase F, a glycosyl asparaginase from Flavobacterium meningosepticum , 1994 .

[56]  A. Telenti,et al.  Silencing of both β-TrCP1 and HOS (β-TrCP2) Is Required To Suppress Human Immunodeficiency Virus Type 1 Vpu-Mediated CD4 Down-Modulation , 2006, Journal of Virology.

[57]  T. Klimkait,et al.  A novel gene of HIV-1, vpu, and its 16-kilodalton product. , 1988, Science.

[58]  D. Baltimore,et al.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. , 1999, Immunity.

[59]  R. Benarous,et al.  Vpu Antagonizes BST-2–Mediated Restriction of HIV-1 Release via β-TrCP and Endo-Lysosomal Trafficking , 2009, PLoS pathogens.

[60]  Bharatwaj Sowrirajan,et al.  The Natural Killer Cell Cytotoxic Function Is Modulated by HIV-1 Accessory Proteins , 2011, Viruses.

[61]  A. Elbein.  Glycosylation inhibitors for N-linked glycoproteins. , 1987, Methods in enzymology.

[62]  U. Schubert,et al.  The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains , 1996, Journal of virology.

[63]  L. Notarangelo,et al.  NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. , 2001, The Journal of experimental medicine.